A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 716 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Working to Make Cancer Clinical Trials More Inclusive: A Q&A With... October 6, 2022 Η ΚΑΘΗΜΕΡΙΝΟΤΗΤΑ December 10, 2018 Adjuvant mRNA-4157 Plus Pembrolizumab Prolongs RFS versus Pembrolizumab Alone in Patients... January 23, 2024 Exosomes May Help Tumors Evade Immune System September 7, 2018 Load more HOT NEWS 7 Tips For Keeping The Entire Family Healthy During Flu Season Adding Lenvatinib to Pembrolizumab Does Not Provide Additional Benefit in Patients... EMA Recommends Extension of Therapeutic Indications for Tremelimumab COVID-19 Testing: What you need to know.
